Recent studies have uncovered thousands of long non-coding RNAs (lncRNAs) in human pancreatic β cells. β cell lncRNAs are often cell type-specific, and exhibit dynamic regulation during differentiation or upon changing glucose concentrations.
Introduction
Transcriptome surveys have uncovered tens of thousands of mammalian transcripts longer than 200 nucleotides that have low protein-coding potential (Carninci et al., 2005; Derrien et al., 2012; Guttman et al., 2009) . A small fraction of these long noncoding RNAs (lncRNAs) have been shown to control gene expression by modulating chromosomal structure, transcription, splicing, mRNA transport, stability or translation (Carrieri et al., 2012; Chen and Carmichael, 2009; Gong and Maquat, 2011; Lai et al., 2013; Luco and Misteli, 2011; Willingham et al., 2005; Yao et al., 2010) . Specific lncRNAs have thus been implicated in various key processes, including random X chromosome inactivation, imprinting, the cell cycle, organogenesis, differentiation, pluripotency, and cancer progression (Guttman et al., 2011; Huarte et al., 2010; Hung et al., 2011; Klattenhoff et al., 2013; Kretz et al., 2013; Penny et al., 1996; Schmitt and Chang, 2013; Sleutels et al., 2002; Ulitsky et al., 2011) . Despite these wide ranging biological roles, the fraction of lncRNAs that is genuinely functional, and the true impact of lncRNAs in human biology and disease remains poorly understood.
Pancreatic β cells regulate glucose homeostasis by secreting the insulin, and play a central role in the pathogenesis of major forms of diabetes mellitus. Recently, more than 1100 lncRNAs were identified in human pancreatic islets and purified β cells (Moran et al., 2012) , as well as in mouse pancreatic islet cells (Benner et al., 2014; Ku et al., 2012; Moran et al., 2012) . A large fraction of human β cell lncRNAs are cell-specific, and several are known to be activated during β cell differentiation (Moran et al., 2012) . This cellular specificity has also been noted for lncRNAs in other cell types (Cabili et al., 2011; Derrien et al., 2012) , and points to the possibility 5 that lncRNAs may regulate genetic programs important for lineage-specific differentiation or specialized cellular functions. Further, several β cell lncRNAs were shown to be regulated by extracellular glucose concentrations, suggesting a potential role of lncRNAs in the functional adaptation of β cells to increased insulin secretory demands (Moran et al., 2012) . Some islet lncRNAs map to loci that contain polygenic or Mendelian defects associated with human diabetes, while selected lncRNAs show deregulation in islets from organ donors with human type 2 diabetes (T2D) (Fadista et al., 2014; Moran et al., 2012) . Collectively, these properties define a newly identified class of candidate regulators of β cell differentiation and function, with potential implications for human diabetes mellitus. However, the true relevance of β cell lncRNAs depends on whether they elicit a physiological function in human β cells, which remains to be addressed systematically.
In the current study, we have focused on a set of lncRNAs that show restricted expression in human pancreatic β cells, and have tested the hypothesis that they regulate β cell gene expression. Our studies have uncovered a regulatory network in which lineage-specific lncRNAs and transcription factors (TFs) control common genes. Furthermore, we show that lncRNAs frequently regulate genes associated with clusters of islet enhancers, which have previously been shown to be the primary functional targets of islet-specific TFs. Detailed analysis of a specific lncRNA named PLUTO controls PDX1, a master regulator of pancreas development and β cell differentiation, and thereby modulates the PDX1-dependent transcriptional program.
Finally, we show that PLUTO and PDX1 are downregulated in islets from organ donors with type 2 diabetes or impaired glucose tolerance, suggesting a potential role in human diabetes.
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Results

Human β cell lncRNA knockdowns cause profound transcriptional phenotypes
To directly test the regulatory function of pancreatic β cell lncRNAs, we carried out loss of function experiments in a glucose-responsive human islet β cell line, EndoC-βH1 (Ravassard et al., 2011) . We chose a human model because only some human lncRNAs are evolutionary conserved (Derrien et al., 2012; Moran et al., 2012; Okazaki et al., 2002; Pang et al., 2006) , and we perturbed the function of lncRNAs through RNAi-based transcript knockdowns rather than genomic deletions because deletions could potentially disrupt cis-regulatory elements. We thus designed lentiviral vectors that contain RNA Polymerase II-transcribed artificial miRNAs (hereafter referred to as amiRNA) with perfect homology to the target sequence so as to elicit target cleavage. The amiRNAs contain an artificial stem sequence targeting our lncRNA of choice as well as flanking and loop sequences from an endogenous miRNA to allow their processing as pre-miRNA by the RNAi pathway ( Figure S1A) . As a reference, we used the same strategy to knockdown TFs that are well known to regulate gene expression in pancreatic islets, as well as five different non-targeting amiRNA sequences as controls.
The lncRNAs selected for knockdown were derived from a shortlist of 25 lncRNAs that showed (i) a markedly enriched expression in human islets and FACS-purified β cells relative to exocrine pancreas and a panel of non-pancreatic tissues, (ii) expression in the EndoC-βH1 β cell line, and (iii) a chromatin profile in human islets that was consistent with an active promoter (Figure S1C-D). Of these 25 lncRNAs, 12 were shortlisted because they were near a protein-coding gene that has an important function in β cells. The lncRNAs had variable subcellular enrichment 7 patterns (Figure S1B) and eight of the 12 lncRNAs had detectable transcripts in orthologous or syntenic mouse regions (Table S1)( Moran et al., 2012) . We then screened four amiRNA sequences for each of the 12 lncRNAs and identified two efficient (>50% knockdown) amiRNAs for 7 lncRNAs, and one efficient amiRNA sequence for the other five lncRNAs (Figure S1E) . Two efficient amiRNAs were also obtained for five essential islet TFs (HNF1A, GLIS3, MAFB, NKX2.2, PDX1) . We thus transduced EndoC-βH1 cells with lentiviruses expressing each amiRNA. This was done in duplicate, or in triplicate for lncRNAs that only had one efficient amiRNA. 80 hrs post-transduction, RNA was harvested and hybridized to oligonucleotide microarrays ( Figure 1A) . For each target gene, we combined expression data from all knockdowns and compared them to the control transductions with five different control amiRNAs to identify genes that were differentially expressed at a significance level of p<10 -3 (ANOVA) ( Figure 1B) .
As expected, the knockdown of islet TFs consistently produced transcriptional phenotypes ( Figure 1B) . Remarkably, the knockdown of 9 of the 12 islet lncRNAs also caused transcriptional changes (Figure 1B, S1F) . A more detailed analysis showed that some of the lncRNAs that presented knockdown phenotypes had visible effects on a neighboring gene, suggesting a possible cis-regulatory mechanism, although other such lncRNAs did not appear to affect neighboring genes, and may thus function through trans-regulatory mechanisms (Figure 1E and S1G) . These loss of function experiments with selected lncRNAs therefore suggested that lncRNAs can regulate the expression of pancreatic β cell genes.
Gene silencing using the RNAi pathway can theoretically lead to nonspecific gene deregulation. In our experimental model, a significant nonspecific result would occur 8 if two unrelated amiRNAs elicited changes in a common set of genes that were not observed in the panel of control non-targeting amiRNAs. To assess the likelihood that two unrelated amiRNA sequences elicit such an effect, we studied the 5 sets of control (non-targeting) amiRNAs, compared all 10 possible combinations of 2 vs. 3 control amiRNAs, and determined the number of differentially expressed genes ( Figure 1C) . Likewise, for each TF or lncRNA which had two valid amiRNAs, we compared the two target-specific amiRNAs against all possible combinations of three control amiRNAs ( Figure 1C ). As seen in Figure 1D , control vs. control comparisons generated a median of 16 (IQR=15-22) differentially expressed genes, whereas all five TFs and six of the seven lncRNA knockdowns led to a significantly higher number of differentially expressed genes (Mann-Whitney test p<10 -4 for all lncRNA/TF vs. control comparisons except HI-LNC75, p=0.004, and HI-LNC76, p>0.5). These results show that the observed phenotypes are unlikely to be caused by unspecific effects of amiRNAs, and indicate that the sequence-specific inhibition of selected islet lncRNAs can result in transcriptional changes comparable in magnitude to the inhibition of well established islet transcriptional regulators.
The primary function of β cells is to synthesize and secrete insulin in response to changes in glucose concentrations. Amongst the genes that showed functional dependence on lncRNAs we identified numerous genes that are known to regulate transcription or secretion in β cells, including RFX6, PDX1, CACNA1D, ATP2A3, ROBO1 and 2, PDE8A, ATP6AP1, KCNJ15, TRPM3, ERO1LB and HADH ( Figure   2A ) (Anderson et al., 2011; Li et al., 2010; Louagie et al., 2008; Okamoto et al., 2012; Smith et al., 2010; Tian et al., 2012; Varadi and Rutter, 2002; Wagner et al., 2008; Yang et al., 2013; Zito et al., 2010) . We therefore measured insulin content and glucose-stimulated insulin secretion (GSIS) in T-antigen excised EndoC-βH3 9 cells after knocking down four lncRNAs that showed the strongest transcriptional phenotypes (HI-LNC12, HI-LNC78, HI-LNC80 and HI-LNC71). Congruent with the broad transcriptional phenotype, we observed reduced insulin content and consequently impaired glucose-stimulated insulin secretion for HI-LNC12, HI-LNC78, and HI-LNC71 knockdowns (Figure 2B) . For HI-LNC78, a glucose-regulated islet transcript (Moran et al, 2012) that is orthologous to mouse Tunar and zebrafish megamind (linc-birc6) lncRNAs (Ulitsky et al., 2011) , there was a reduction in GSIS after correcting for the reduction in insulin content (p=0.002) ( Figure S2A) . To further validate these effects, the same lncRNAs were downregulated using antisense locked nucleic acids (LNA TM GapmeRs, Exiqon), which also led to impaired insulin secretion after knockdown of HI-LNC12 and HI-LNC78 (Figure S2B ). Taken together, lncRNA knockdown studies identified lncRNAs that modulate gene expression and consequently insulin secretion in a human β cell line.
Human islet lncRNAs and TFs regulate common gene expression programs
To gain insight into the expression programs that are regulated by islet-specific lncRNAs and TFs, we compared their knockdown gene expression phenotypes. We first assessed changes in gene expression occurring after knockdown of the different islet TFs, and found high Pearson correlation values for all pairwise comparisons (r = 0.4-0.8, p<10 -27 ) (Figure 3A, S3 ). This finding is consistent with the notion that isletspecific TFs often bind to common genomic targets and function in a combinatorial manner (Pasquali et al., 2014; Qiu et al., 2002; Wilson et al., 2003) . Interestingly, the transcriptional changes that occurred after the inhibition of several lncRNAs significantly correlated with those observed following inhibition of TFs ( Figure 3A and S3, see also a cluster analysis of TF and lncRNA-dependent changes in Figure   3B ). Some pairwise comparisons that illustrate this finding include HI-LNC78-dependent gene expression changes, which correlated highly with HNF1A and MAFB dependent changes (Pearson´s r=0.87 and 0.89, respectively, p<10 -71 ), and HI-LNC15-dependent changes, which correlated with those occurring after knockdown of NKX2-2 (r=0.67, p=10 -32 ) (Figure 3C) . The results from these gene knockdown experiments therefore indicate that selected islet-specific lncRNAs and TFs can regulate common gene expression programs.
Islet TFs and lncRNAs co-regulate genes associated with enhancer clusters
Recent studies have revealed that islet TFs regulate cell-specific transcription by targeting clusters of enhancers, and in particular clusters with enhancers that are bound by multiple islet TFs (Pasquali et al., 2014) . Enhancer clusters share many features with regulatory domains that have otherwise been defined as "stretch enhancers" or "super-enhancers" (Pasquali et al., 2014; Pott and Lieb, 2015) . Given that knock-down of islet lncRNAs and TFs suggested that they regulate similar genes, we asked if islet lncRNAs also regulate enhancer cluster-associated genes.
As expected, Gene Set Enrichment Analysis (GSEA) showed that genes with isletenriched expression, genes associated with enhancer clusters, or genes associated with enhancers that are bound by multiple TFs were downregulated after knockdown of all five TFs, whereas this was not observed for ten control sets of genes expressed at similar levels (Figure 4, Figure S4A,B) . Likewise, genes associated with enhancer clusters and those showing islet-specific expression were also enriched among genes that were downregulated after knockdown of HI-LNC12, 15, 30, 78, 80, 85 and 71 (Figure 4, Figure S4A,B) . These results therefore indicate that islet-specific TFs and lncRNAs often co-regulate genes that are associated with enhancer clusters.
β cell lncRNAs and TFs form part of islet-specific co-expression networks.
We next used an independent experimental approach to validate the observations that human β cell lncRNAs and TFs regulate common gene expression programs.
This involved the analysis of gene modules that show co-expression across a panel of human islet RNA samples. Analogous approaches have been employed to reveal sets of genes that share functional relationships (Derry et al., 2010; Kim et al., 2001; Pandey et al., 2010; Segal et al., 2003; Stuart et al., 2003; Su et al., 2011) . We implemented this analysis using weighted gene co-expression analysis (WGCNA) of RNA-seq profiles from 64 human pancreatic islet samples. This identified 25 major gene modules containing >100 genes, named M1-M25, which showed highly significant co-expression across human islet samples ( Figure 5A , Table S2 ). We next determined which co-expression modules contained islet lncRNAs. Rather than using our previously defined set of lncRNAs, this analysis was performed with a set of 2373 β cell lncRNAs that was newly annotated using ~5 billion stranded RNA-seq reads pooled from 41 islet samples (Table S3 , Figure S5A ). β cell lncRNAs were found to be enriched in seven pancreatic islet co-expression modules (M3, M7, M12, M13, M18, M20, M21) ( Figure 5B ).
We next characterized the nature of these seven lncRNA-enriched co-expression modules. Five of these (M3, M7, M12, M18, M20) were enriched in genes associated with pancreatic islet enhancer clusters (Figure 5A -C, marked in blue). Two other modules (M13, M21) were enriched for ubiquitously expressed genes involved in mRNA translation and metabolic pathways (Figure S5B) . Amongst the modules enriched in lncRNAs and enhancer clusters, three (M3, M7, M18) were also enriched in islet-specific TF genes (Figure 5D ), and two of these modules (M3, M7) contained nine of the 12 lncRNAs that had been knocked down in EndoC-βH1 cells. Module M3, the largest of the seven lncRNA-enriched modules, featured gene ontology (GO) terms associated with prototypical islet cell functions and contained several islet TFs and lncRNAs ( Figure 5E ). In keeping with these findings, we found numerous instances of islet lncRNAs and known cell-specific TFs that showed a tight correlation of gene expression levels across human islet samples (Figure 5F, S5C) .
These findings thus indicated that β cell-specific lncRNAs, TFs, and genes associated with islet enhancer clusters form part of common expression programs.
Further analysis is consistent with the notion that lncRNAs play a functional role in driving gene expression variation in the lncRNA-enriched co-expression modules.
First, the subset of lncRNAs that were shown to regulate an adjacent gene in knockdown studies also exhibited a particular high co-regulation with the adjacent gene across islet samples (Figure S1G) . This observation was extended to define 292 lncRNAs that displayed a highly significant (p<10 -7 ) correlation of expression with an adjacent protein-coding gene in the panel of human islet samples, and are thus candidate cis-regulatory lncRNAs (Table S6) . Second, we analyzed all genes that were significantly downregulated in EndoC-βH1 cells after knocking down HI-LNC12, 71, 78 and 80, and found that they were also enriched amongst genes in human islet modules M3, M7 and M18, but not in size-controlled modules ( Figure   S5D ). In summary, co-expression analysis of native human islets corroborated the findings observed with amiRNA-based perturbations in EndoC-βH1 cells, and indicated that a group of islet lncRNAs and TFs form part of common transcriptional networks that target clusters of pancreatic islet enhancers (Figure 5G) .
Deregulation of β cell lncRNAs in human T2D
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The identification of functional lncRNAs led us to explore whether some lncRNAs are abnormally expressed in human T2D, and might thus be relevant to the pathogenesis of this disease. We therefore analyzed our new set of 2373 lncRNAs in a recently reported gene expression dataset that includes human islet samples from donors diagnosed with T2D or impaired glucose tolerance (IGT) (Fadista et al., 2014) . Our results showed that, despite the fact that gene expression across human islet donors is highly variable, the expression of 15 and 100 lncRNAs was significantly altered in islets from T2D and IGT vs. non-diabetic donors, respectively (adjusted p<0.05) ( Figure S6A , see Table S7 for a complete list). This finding suggests a potential role of functional β cell lncRNAs in driving some of the β cell gene expression changes that are associated with T2D.
PLUTO regulates PDX1, an essential transcriptional regulator
To explore how β cell lncRNAs can regulate cell-specific transcriptional networks, we focused on HI-LNC71, a nuclear-enriched transcript (Figure S1B ) that is transcribed from a promoter that is located ~3 kb upstream of PDX1, in an antisense orientation ( Figure S6B) . PDX1 is an essential transcriptional regulator of pancreas development and β cell function that has been implicated in genetic mechanisms underlying Mendelian and type 2 diabetes (Ahlgren et al., 1998; Jonsson et al., 1994; Offield et al., 1996; Stoffers et al., 1997) . Based on this genomic location, we renamed HI-LNC71 as PLUTO, for PDX1 Locus Upstream Transcript.
The potential importance of PLUTO was strengthened by the observation that PLUTO was among the most markedly downregulated lncRNAs in islets from T2D or IGT donors (adjusted p-value = 0.07 and 0.005, respectively, Figure 6A, S6B) .
Interestingly, PDX1 was also downregulated in islets from donors with T2D and IGT ( Figure 6A) .
PLUTO is a multi-isoform transcript that contains five major exons that span nearly 100 kb, encompassing a cluster of enhancers that make three-dimensional (3D) contacts with the PDX1 promoter in human islets and in EndoC-βH1 cells (Figure   6B, S6A) . This observation suggested that PLUTO could affect cis-regulation of the PDX1 gene.
To test whether PLUTO regulates PDX1, we first examined EndoC-βH1 cells after amiRNA-mediated knockdown of PLUTO RNA, and found reduced PDX1 mRNA and protein levels (Figure 6C) . Similarly, knockdown of PLUTO RNA in dispersed primary human islet cells caused decreased PDX1 mRNA (Figure 6D) . To validate these experiments through a complementary approach, we used CRISPR interference (CRISPRi), which involves targeting guide RNAs (gRNAs) downstream of a gene's transcriptional initiation site to block its transcription. Two independent gRNAs that targeted a region downstream of the PLUTO initiation site efficiently reduced PLUTO RNA levels relative to non-targeting gRNAs, and in both cases this led to decreased PDX1 mRNA expression ( Figure 6E) . Therefore, perturbing either PLUTO RNA levels or its transcription leads to the same inhibitory effect on PDX1 mRNA.
The mouse Pdx1 locus also has an islet lncRNA (Pluto) that shows only limited sequence homology with human PLUTO. Pluto is also transcribed from the opposite strand of Pdx1, but is initiated from a promoter within the first intron of Pdx1, and like PLUTO, spans a broad regulatory domain upstream of Pdx1 (Figure S6C) .
Knockdown of Pluto RNA in the mouse β cell line MIN6 also led to decreased Pdx1 mRNA levels (Figure S6E) . These experiments therefore indicated that PLUTO regulates PDX1 mRNA in human β cell lines and primary islet cells, and an analogous effect was observed for the mouse lncRNA ortholog.
Consistent with this regulatory relationship, PLUTO and PDX1 RNA levels are highly correlated across islet samples (Pearson´s r=0.86, p=10 -15 , Figure 6F) , and knockdown of PDX1 and PLUTO in EndoC-βH1 cells resulted in the deregulation of a shared set of genes (Figure 6G-J) . Furthermore, Pluto and Pdx1 were found to be regulated with nearly identical dynamics in response to a shift in glucose concentration (4 to 11 mM) in mouse pancreatic islets (Figure S6D) . PLUTO and PDX1 therefore regulate a common program in pancreatic islets, and this is at least in part explained by the fact that PLUTO regulates PDX1.
PLUTO regulates PDX1 transcription and local 3D chromatin structure
To assess the mechanisms underlying the function of PLUTO, we first examined if PLUTO controls the stability or transcription of PDX1. Transcriptional inhibition experiments using Actinomycin D showed no significant differences in the stability of PDX1 mRNA upon PLUTO knockdown (Figure 7A) . By contrast, intronic PDX1 RNA was reduced upon PLUTO knockdown, suggesting that PLUTO regulates PDX1 transcription (Figure 7B) .
Because PLUTO spans an enhancer cluster, we hypothesized that it could regulate the chromatin state of active enhancers. We thus knocked down PLUTO in β cells and measured H3K27 acetylation, as well as H3K4 mono and tri-methylation levels at several enhancers within the cluster. Our results indicate no significant changes in these characteristic active chromatin marks (Figure S7) .
We next determined whether PLUTO affects the 3D contacts between the enhancer cluster and the PDX1 promoter. Examination of the PDX1 locus using quantitative chromatin conformation capture (3C) assays revealed that two far upstream enhancers (Figure 7C) showed reduced contacts with the PDX1 promoter after PLUTO knockdown (Figure 7D) . These findings therefore show that PLUTO regulates the transcription of PDX1, a key pancreatic β cell transcriptional regulator, and that this is associated with its ability to promote contacts between the PDX1 promoter and its enhancer cluster (Figure 7E) .
Discussion
In the current study we have tested the hypothesis that lncRNAs play a role in cellspecific gene regulation in pancreatic β cells, a cell type that is central in the pathogenesis of human diabetes. We have thus carried out for the first time a systematic analysis of the function of a set of human β cell-specific lncRNAs. Our experiments revealed several examples of β cell lncRNAs in which sequencespecific perturbation causes transcriptional and functional phenotypes. We have further shown that β cell-specific lncRNAs and TFs regulate a common transcriptional network. Finally, we have demonstrated that β cell-specific lncRNAs directly or indirectly participate in the regulation of human enhancer clusters, which are the major functional targets of islet-specific transcription factors and key cisregulatory determinants of islet cell transcriptional programs (Pasquali et al., 2014) . Importantly, these conclusions are supported by concordant results from coexpression network analysis and loss of function experiments. These studies should be interpreted in light of previous evidence indicating that a significant fraction of lncRNAs show lineage-specific expression (Cabili et al., 2011; Derrien et al., 2012; Goff et al., 2015; Guttman et al., 2011; Iyer et al., 2015; Moran et al., 2012; Pauli et al., 2012) . Our study extends previous findings by demonstrating a functional role of lncRNAs in lineage-specific TF networks.
Our findings invite the question of what molecular mechanisms underlie the regulatory effects of β cell lncRNAs. LncRNAs have been proposed to control gene expression through diverse molecular mechanisms, including the formation of protein-specific interactions and scaffolds, RNA-DNA or RNA-RNA hybrids, the titration of miRNAs, and the modulation of 3D chromosomal structures (Rinn and Chang, 2012; Wang and Chang, 2011) , while some transcripts currently defined as lncRNAs can theoretically encode for atypical small peptide sequences (Andrews and Rothnagel, 2014) . Our knockdown and co-expression analyses have identified a subset of functional lncRNAs that appear to regulate a nearby gene, suggesting a lncRNA-based cis-regulatory mechanism, while others are likely to exert transregulatory effects. We focused on one functional nuclear-enriched β cell lncRNA, PLUTO, and found that its function in β cell networks is at least in part due to its ability to elicit an effect on the transcription of its adjacent gene, PDX1, which encodes for a key β cell transcription factor. Importantly, this was observed for both the mouse and human orthologs, and similar effects were obtained through RNAi suppression or through CRISPR-induced transcriptional interference of PLUTO. Our studies further showed that PLUTO promotes 3D interactions between the PDX1 promoter and its upstream enhancer cluster, which is contained within the body of the PLUTO gene. We thus propose that PLUTO regulates the 3D architecture of the enhancer cluster at the PDX1 locus. This finding is reminiscent, yet distinct from earlier examples of non-coding RNA genes that modulate 3D chromosomal structure (Lai et al., 2013; Yao et al., 2010) . Given that a significant number of lncRNAs are co-expressed with adjacent lineage-specific protein-coding genes, it is possible that 18 the general regulatory paradigm described here is relevant to analogous lncRNAprotein coding gene pairs. Taken together, our data implicate cell-specific lncRNAs in human β cell transcriptional programs. Given the importance of TFs in the pathophysiology of human diabetes and their role in β cell programming strategies, it now seems reasonable to explore whether β cell lncRNAs also play analogous roles (Bell and Polonsky, 2001; Flanagan et al., 2014; Zhou et al., 2008) . The findings reported here therefore strengthen earlier suggestions that defects in β cell lncRNAs might contribute to the pathogenesis of human diabetes (Fadista et al., 2014; Moran et al., 2012) , and warrant an assessment of whether they can be harnessed to promote β cell differentiation, function or cellular mass.
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Experimental procedures.
Pancreatic Islets
Human islets used for RNA-seq and ChIP-seq were cultured with CMRL 1066 medium containing 10% Fetal Calf Serum (FCS) before shipment, after which they were cultured for three days with RPMI 1640 medium containing 11 mM glucose, supplemented with 10% FCS.
Glucose stimulated insulin release
Glucose stimulated insulin release was assayed in EndoC-βH1 or EndoC-βH3 cells as described (Benzara et al., 2015 , Ravassard et al., 2011 .
RNA analysis
RNA was isolated with Tripure (Roche) and treated with DNase I (Sigma). qPCR was performed with SYBR green or Taqman probe detection (van Arensbergen et al., 2010) . See Table S4 for oligonucleotide and probe sequences.
amiRNA and CRISPRi experiments
Lentiviral vectors carrying amiRNAs targeting TFs, lncRNAs and non-targeting control sequences were transduced into the EndoC-βH1 human β cell line as described (Castaing et al., 2005; Ravassard et al., 2011; Scharfmann et al., 2014) . Figure S1A illustrates the vector design. Oligonucleotide sequences are shown in Table S4 . Non-transduced cells were assayed in parallel. Cells were harvested at 80 hours post transduction for RNA extraction. For transduction of human islets, islets were first dispersed using trypsin-EDTA and gentle agitation. CRISPRi experiments 20 were performed with two gRNAs designed to target PLUTO exon 1, or two unrelated intergenic control regions, and transfected in EndoC-βH3 cells (Table S4 ).
Gene expression array analysis
RNA was hybridized onto HTA2.0 Affymetrix arrays. RMA normalization was carried out using Expression Console (Affymetrix). Gene based differential expression analysis was done using Transcriptome Analysis Console (TAC, Affymetrix).
Enhancer cluster genes were defined by genes that were associated with clustered islet enhancers that show top 50 percentile binding by TFs (PDX1, FOXA2, NKX2-2, NKX6.1, MAFB), as defined previously (Pasquali et al., 2014) . Pancreatic islet gene sets used for enrichment analysis are shown in Table S5 . A list of islet-enriched genes was generated as those with more than two standard deviations higher expression in human islets than the average expression in 16 human tissues (Table   S5 ). Data (cel and chp files) can be found at Gene Expression Omnibus (GEO, accession: GSE83619).
Differential expression in IGT and T2D islets.
RNA-seq data has been previously described (Fadista et al., 2014) . The samples were aligned to the hg19 genome using STAR aligner version 2.3.0 as described in supplemental methods, quantification was carried out with HTseq-Count 0.6.1, and differential expression analysis of lncRNA genes was done using DEseq2 1.10 (Table S3 ), using an adjusted p-value threshold of 0.05.
Chromatin conformation capture (3C)
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3C and 4C-seq was carried out as previously described (Pasquali et al., 2014; Tena et al., 2011) For real-time PCR quantification, readings were normalized to a control region within the PDX1 intron. Normalized values are expressed as a fraction of nontargeting amiRNA control sample. See Table S4 for oligonucleotide sequences.
Annotation of islet lncRNAs.
LncRNAs were annotated through de novo assembly of ~5 billion stranded pairedend RNA-seq reads from 41 human islet samples, filtered for expression in FACSpurified β cell cells, lack of enrichment in the pancreatic exocrine fraction to exclude acinar contaminants, and presence of presence of H3K4me3 enrichment in the vicinity of the 5' end. A more detailed description of the annotation process is provided in supplemental methods. Annotations are available in Table S3 and can be accessed on a UCSC genome browser (GRCh37/hg19) session by selecting "track hubs", and selecting "Human Islet lncRNAs". Alternatively the track hub can be directly visualized in the UCSC Genome Browser.
Network analysis
WGCNA(v2) tool was used to build a co-transcriptional network based on mRNAs from 64 human islet RNA-seq samples. analysis (GSEA) showed that genes that were downregulated upon knockdown of 33 either islet TFs or lncRNAs were enriched in a set of 694 genes that is associated with human islet enhancer clusters (red dots), but not in 10 control gene sets (black dots) that were expressed at similar levels as enhancer cluster genes. ADCY8  COG3  COPG2  CTNNB1  DOPEY1  EXOC4  HADH  KCNJ3  PDE8A   ADCY8  ATP2A3  ATP6AP1  CACNA1A  CACNA1D  CADM1  CADPS  CREBBP  GNAS  HADH   HI-LNC12   β-cell function genes regulated by lncRNAs   ERO1LB  HADH  KCNJ3  TM4SF4  PDX1  VAMP3   HI-LNC78  HI-LNC71   KCNJ15  NFAT5  PAX6  PCSK2  PDE8A  ROBO1  ROBO2  SCIN  TM4SF4  TRPM3   PGK1  PRKAR2A  RFX3  RFX6  ROBO1  SLC25A6  STAT3  TM4SF4 
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